about
The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic reviewAcceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness thresholdEconomic and outcomes consequences of TachoSil®: a systematic review.Cost-effectiveness of transcatheter versus surgical management of structural heart disease.Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache.The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.Demonstrating the value of medicines: evolution of value equation and stakeholder perception of uncertainties.Cost-utility of cognitive behavioral therapy for low back pain from the commercial payer perspective.Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review.[Collaborative and stepped care for depression: Development of a model project within the Hamburg Network for Mental Health (psychenet.de)].The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?What is known about the cost-effectiveness of orphan drugs? Evidence from cost-utility analyses.Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
P2860
Q26801751-9E9040A3-F24E-4B2B-AB46-D24E65F18CF6Q28607835-234D4710-928E-4ADB-921A-A9B0B50884B5Q34198785-9DDEAA0C-617D-4431-80F1-4563C7096B52Q36134563-0D0CDB95-F5E2-42EA-9E36-86CF865EAAD3Q36823467-3F896B64-9440-46E8-9D1E-DB65CFD82DC3Q36987575-A6060021-1494-4FC4-A60C-40A0D7EE41FEQ37116554-487E9829-7C7C-4967-8032-8561E3F42E70Q37189974-3171FA1B-A1B5-4C5B-B617-D67EA8DDAD72Q38074916-F482D598-8751-494B-BA69-9DEC60BD7E7AQ38391776-C21ECDBD-A8FA-472D-9C63-D0CE896EF94CQ40397786-49F6DAC4-D325-461D-A256-A5C7E12A1553Q41043413-73302E2F-5CF5-4BC1-A544-79B19B244F58Q41526451-D0D3AB34-A413-42B8-8611-24BEF711564A
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
How to assess the value of medicines?
@ast
How to assess the value of medicines?
@en
How to assess the value of medicines?
@nl
type
label
How to assess the value of medicines?
@ast
How to assess the value of medicines?
@en
How to assess the value of medicines?
@nl
prefLabel
How to assess the value of medicines?
@ast
How to assess the value of medicines?
@en
How to assess the value of medicines?
@nl
P2860
P356
P1476
How to assess the value of medicines?
@en
P2093
Steven Simoens
P2860
P356
10.3389/FPHAR.2010.00115
P577
2010-09-07T00:00:00Z